Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen for Patients With Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma Underwenting Haploidenticl Peripheral Blood Stem Cell Transplantation
Latest Information Update: 18 Oct 2021
At a glance
- Drugs Ruxolitinib (Primary) ; Tucidinostat (Primary) ; Busulfan; Carmustine; Cyclophosphamide; Cytarabine
- Indications Graft-versus-host disease; Precursor T-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 18 Oct 2021 New trial record